Radiotherapeutisch Instituut Friesland Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2016
NCT02442375
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

Radiotherapeutic Institute Friesland